However, mutations in MSH6 and MSH2 were substantially enriched (Table 2) and merit further consideration as FBC predisposition genes.21 Heterozygous mutations in MUTYH were not associated with increased breast cancer risk. This evidence concerns the gene MSH2 and breast cancer.